-
Angkasekwinai, N, Niyomnaitham, S, Sewatanon, J, Phumiamorn, S, Sukapirom, K, Senawong, S, Mahasirimongkol, S, Toh, ZQ, Umrod, P, Somporn, T, et al.
The immunogenicity and safety of different COVID-19 booster vaccination following CoronaVac or ChAdOx1 nCoV-19 primary series.
2024
view publication
-
Niyomnaitham, S, Toh, ZQ, Wongprompitak, P, Jansarikit, L, Srisutthisamphan, K, Sapsutthipas, S, Jantraphakorn, Y, Mingngamsup, N, Licciardi, PV, Chokephaibulkit, K.
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac and ChAdOx1 and BNT162b2 plus heterologous BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults.
2024
view publication
-
Tosif, S, Haycroft, ER, Sarkar, S, Toh, ZQ, Anh-ha, DL, Donato, CM, Selva, KJ, Hoq, M, Overmars, I, Nguyen, J, et al.
Virology and immune dynamics reveal high household transmission of ancestral SARS-CoV-2 strain.
2024
view publication
-
Niyomnaitham, S, Chatsiricharoenkul, S, Toh, ZQ, Senawong, S, Pheerapanyawaranun, C, Phumiamorn, S, Licciardi, PV, Chokephaibulkit, K.
Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot study.
2024
view publication
-
Chatsiricharoenkul, S, Niyomnaitham, S, Posen, HJ, Toh, ZQ, Licciardi, PV, Wongprompitak, P, Duangchinda, T, Pakchotanon, P, Chantima, W, Chokephaibulkit, K.
Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination.
2024
view publication